Back to School: How biopharma can reboot drug development. Access exclusive analysis here

HAE results

HAE results

Company Product Data Status
Dyax DX-88 yeast-derived recombinant plasma kallikrein inhibitor Ph III EDEMA3, n=72: Symptom improvement at 4 hrs: significant vs.

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE